
The data on 645 patients with anaplastic neuroepithelial tumors subjected to radiotherapy, irradiation with radiosensitizers (metronidazole) and chemoradiotherapy are presented. Total-differential brain irradiation was applied: 10-40 Gy on the whole brain and 10-20 Gy on the tumor bed. Fractionation depended on tumor radiosensitivity. The median survival time for anaplastic astrocytoma was 50 +/- 5.6 mos., oligodendroglioblastoma - 42 +/- 7.4 mos., ependymoblastoma - 61 +/- 8.2 mos. and glioblastoma - 22 +/- 1.5 mos. High-dose dynamic fractionation proved to be most effective in cases of glioblastoma. The outcome of glioblastoma was modified neither by radiosensitizers nor by cytotoxic agents.
Radiation-Sensitizing Agents, Brain Neoplasms, Oligodendroglioma, Antineoplastic Agents, Electrons, Radiotherapy Dosage, Glioma, Astrocytoma, Combined Modality Therapy, Ependymoma, Humans, Neuroectodermal Tumors, Primitive, Peripheral, Cobalt Radioisotopes
Radiation-Sensitizing Agents, Brain Neoplasms, Oligodendroglioma, Antineoplastic Agents, Electrons, Radiotherapy Dosage, Glioma, Astrocytoma, Combined Modality Therapy, Ependymoma, Humans, Neuroectodermal Tumors, Primitive, Peripheral, Cobalt Radioisotopes
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
